Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Boston MA, Ann Arbor MI, Dallas TX, Houston TX,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06053658

Phase2, Recruiting

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Location: Boston MA, New York NY, Detroit MI, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07393282

Phase3, Recruiting

Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss

for
GJB2-mediated Hearing Loss, GJB2 Gene Mutation, DFNB1A
Location: Boston MA, Allentown PA, Bethesda MD, Oklahoma City OK
Sponsor: Skylark Bio Inc.

Sex: All

Age: 0 - 7

Code: NCT07627971

Phase1, Phase2, Recruiting

Teenthrive 2: Treatments for Improving Mood in Teens

for
Depression in Adolescence
Location: Boston MA, Columbus OH
Sponsor: Butler Hospital

Sex: All

Age: 12 - 18

Code: NCT07475845

Recruiting

Project EMPOWER-OCD

for
Obsessive-Compulsive Disorder
Location: Boston MA
Sponsor: Boston University Charles River Campus

Sex: All

Age: 18+

Code: NCT07158801

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control

for
Myopia
Location: Boston MA, Philadelphia PA, Norfolk VA, Durham NC,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 5 - 11

Code: NCT07095894

Phase3, Recruiting

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Methuen MA, New York NY, Rockville MD,
Sponsor: Tonix Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07621237

Phase2, Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07621718

Phase3, Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Worcester MA, Westerly RI, Waterford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase2, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Boston MA, The Bronx NY, New York NY, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

Safety and Performance Assessment of the Sphere-9ā„¢ Catheter and Afferaā„¢ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

for
Ventricular Tachycardia (VT)
Location: Boston MA, New York NY, Philadelphia PA, Cleveland OH,
Sponsor: Medtronic Cardiac Ablation Solutions

Sex: All

Age: 18 - 70+

Code: NCT06703489

Recruiting

Global Trial in APG2575 for Patients With CLL/SLL

for
CLL/SLL
Location: Boston MA, Halifax, Richmond VA, Greenville NC,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18 - 70+

Code: NCT06104566

Phase3, Recruiting

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Pyxis Oncology, Inc

Sex: All

Age: 18+

Code: NCT06795412

Phase1, Phase2, Recruiting

CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

for
Solid Tumors, GI Cancer
Location: Boston MA, Baltimore MD, Washington DC, Durham NC,
Sponsor: Curegenix Inc.

Sex: All

Age: 18+

Code: NCT02675946

Phase1, Recruiting

Efficacy of the OmnipodĀ® 6 System Compared With the OmnipodĀ® 5 System

for
Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Location: Boston MA, New Haven CT, Detroit MI, Indianapolis IN,
Sponsor: Insulet Corporation

Sex: All

Age: 14 - 70+

Code: NCT07579702

Recruiting

Evaluation of the Fully Closed Loop OmnipodĀ® System in Type 2 Diabetes

for
Type 2 Diabetes Mellitus
Location: Boston MA, New York NY, Syracuse NY, Newport News VA,
Sponsor: Insulet Corporation

Sex: All

Age: 18 - 70+

Code: NCT07521475

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for
Macular Edema Secondary to Inflammation
Location: Boston MA, Waterford CT, Manchester CT, Greenwich CT,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase3, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Plymouth MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase3, Recruiting

Assessing Optimal XRB Initiation Points in Jail

for
Opioid Use Disorder
Location: Boston MA, Springfield MA, New York NY,
Sponsor: NYU Langone Health

Sex: Male

Age: 0+

Code: NCT06051890

Recruiting

Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, Durham NC, Chapel Hill NC, Cincinnati OH,
Sponsor: Prolexys Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01695590

Phase1, Phase2, Recruiting